BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11480318)

  • 1. Effects of vaccination with several mycobacterial proteins and lipoproteins on Mycobacterium leprae infection of the mouse.
    Ngamying M; Varachit P; Phaknilrat P; Levy L; Brennan PJ; Cho SN
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):43-5. PubMed ID: 11480318
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination of mice against the leprosy bacillus with skin-test antigens.
    Ngamying M; Levy L; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):305-7. PubMed ID: 10575412
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
    Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
    Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.
    Roche PW; Neupane KD; Failbus SS; Kamath A; Britton WJ
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):93-8. PubMed ID: 11757171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
    Chaitra MG; Nayak R; Shaila MS
    Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
    Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
    Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of the protein antigens of Mycobacterium leprae. Their potential use for the development of a vaccine against leprosy].
    Vega-López F; Macotela-Ruiz E
    Gac Med Mex; 1991; 127(1):31-9. PubMed ID: 1959737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
    Nomaguchi H; Mukai T; Takeshita F; Matsuoka M; Maeda Y; Aye TM; Jahan N; Yogi Y; Endo M; Sato Y
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):182-90. PubMed ID: 12483966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against leprosy.
    Gupte MD
    Indian J Lepr; 1991; 63(3-4):342-9. PubMed ID: 1804888
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccination of mice against M. leprae infection.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):222-6. PubMed ID: 776860
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoprophylaxis against Mycobacterium leprae infection with subunit vaccines.
    Britton WJ; Martin E; Kamath AT; Neupane KD; Roche PW
    Lepr Rev; 2000 Dec; 71 Suppl():S176-81. PubMed ID: 11201878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads.
    Gelber RH; Mehra V; Bloom B; Murray LP; Siu P; Tsang M; Brennan PJ
    Infect Immun; 1994 Oct; 62(10):4250-5. PubMed ID: 7927681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the preparation of an antileprosy vaccine from armadillo-derived Mycobacterium leprae.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):515-8. PubMed ID: 6368415
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.
    Raman VS; O'Donnell J; Bailor HR; Goto W; Lahiri R; Gillis TP; Reed SG; Duthie MS
    Infect Immun; 2009 Dec; 77(12):5623-30. PubMed ID: 19786561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. South India immunoprophylaxis trial against leprosy: relevance of findings in the context of leprosy trends.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S10-3. PubMed ID: 11757173
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on leprosy vaccination.
    Kato L
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):693-4. PubMed ID: 2674307
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of mice against mycobacterial infection by lymphoid cell vaccination.
    Levy L; Enk CD; Zipris D; Cohen IR
    Isr J Med Sci; 1994 Jan; 30(1):22-5. PubMed ID: 8138393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.